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Abstract Pre-clinical studies have shown that treatment
by pulsed electromagnetic ﬁelds (PEMFs) can limit the
catabolic effects of pro-inﬂammatory cytokines on artic-
ular cartilage and favour the anabolic activity of the
chondrocytes. Anterior cruciate ligament (ACL) recon-
struction is usually performed by arthroscopic procedure
that, even if minimally invasive, may elicit an inﬂam-
matory joint reaction detrimental to articular cartilage. In
this study the effect of I-ONE PEMFs treatment in
patients undergoing ACL reconstruction was investigated.
The study end-points were (1) evaluation of patients’
functional recovery by International Knee Documentation
Committee (IKDC) Form; (2) use of non-steroidal anti-
inﬂammatory drugs (NSAIDs), necessary to control joint
pain and inﬂammation. The study design was prospective,
randomized and double blind. Sixty-nine patients were
included in the study at baseline. Follow-up visits were
scheduled at 30, 60 and 180 days, followed by 2-year
follow-up interview. Patients were evaluated by IKDC
Form and were asked to report on the use of NSAIDs.
Patients were randomized to active or placebo treatments;
active device generated a magnetic ﬁeld of 1.5 mT at
75 Hz. Patients were instructed to use the stimulator (I-
ONE) for 4 h per day for 60 days. All patients underwent
ACL reconstruction with use of quadruple hamstrings
semitendinosus and gracilis technique. At baseline there
were no differences in the IKDC scores between the two
groups. At follow-up visits the SF-36 Health Survey score
showed a statistically signiﬁcant faster recovery in
the group of patients treated with I-ONE stimulator
(P\0.05). NSAIDs use was less frequent among active
patients than controls (P\0.05). Joint swelling resolution
and return to normal range of motion occurred faster in
the active treated group (P\0.05) too. The 2-year fol-
low-up did not shown statistically signiﬁcant difference
between the two groups. Furthermore for longitudinal
analysis the generalized linear mixed effects model was
applied to calculate the group 9 time interaction coefﬁ-
cient; this interaction showed a signiﬁcant difference
(P\0.0001) between the active and placebo groups for
all investigated variables: SF-36 Health Survey, IKDC
Subjective Knee Evaluation and VAS. Twenty-nine
patients (15 in the active group; 14 in the placebo group)
underwent both ACL reconstruction and meniscectomy;
when they were analysed separately the differences in SF-
36 Health Survey scores between the two groups were
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DOI 10.1007/s00167-008-0519-9larger then what observed in the whole study group
(P\0.05). The results of this study show that patient’s
functional recovery occurs earlier in the active group. No
side effects were observed and the treatment was well
tolerated. The use of I-ONE should always be considered
after ACL reconstruction, particularly in professional
athletes, to shorten the recovery time, to limit joint
inﬂammatory reaction and its catabolic effects on articular
cartilage and ultimately for joint preservation.
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Introduction
Articular cartilage performs mechanical functions absorb-
ing the different loads applied to a joint in the course of
daily activity [19]. Homeostasis and mechanical compe-
tence of cartilage are regulated by the activity of the
chondrocytes that maintain the function and the integrity of
the extracellular matrix, proteoglycans and collagen.
In consideration of the scant repairability of the carti-
lage, even modest damages resulting from trauma or
inﬂammation may be the starting point for cartilage
degeneration leading over time to extensive lesions that
deepen into the thickness of the cartilage itself, ultimately
exposing the subchondral bone tissue [3, 17].
Joint injury may involve synovial tissue, cartilage and
subchondral bone leading to joint inﬂammation, swelling
and pain. Surgical interventions must certainly be included
among the triggers of inﬂammatory reaction in a joint [12].
The development of arthroscopic procedures has
undoubtedly limited joint damage associated to surgery for
reconstruction of ligaments; nevertheless, it does not avoid
the inﬂammatory response. Thus, while arthroscopic pro-
cedures make surgery less invasive, the inﬂammatory
response at the joint remains and the release of pro-
inﬂammatory cytokines in the synovial ﬂuid is associated
with an increase in the aggrecanase activities that lead to a
degradation of the cartilage matrix, and also inhibit pro-
teoglycan synthesis [11, 15, 18]. To prevent cartilage
damage, current pharmacological therapies aim to control
the catabolic effects of the pro-inﬂammatory cytokines and
enhance anabolic activity, proteoglycan synthesis and
proliferation of chondrocytes. Drugs that combine the
above effects are called chondroprotectors; in this category
should be included drugs with A2A adenosine receptor
agonist activity, able to stimulate the physiological path-
ways that control inﬂammation and promote chondrocyte
anabolic activities. Nevertheless, these drugs are in early
stages of clinical testing [5].
Pre-clinical studies have shown that pulsed electro-
magnetic ﬁelds (PEMFs) in vitro favour the proliferation of
chondrocytes [6, 16], stimulate proteoglycan synthesis [7]
and demonstrate an A2A adenosine receptor agonist activity
[20, 21]. Electromagnetic ﬁelds in vivo prevent degenera-
tion of articular cartilage and down-regulate the synthesis
and release of pro-inﬂammatory cytokines in the synovial
ﬂuid [2, 4, 8, 9]. These ﬁndings suggest that electromag-
netic ﬁelds may be used to control joint inﬂammation and
to stimulate cartilage anabolic activities, ﬁnally resulting in
chondroprotection.
A clinical study performed in patients undergoing
arthroscopic treatment for cartilage lesions showed that
biophysical treatment with PEMFs was well tolerated by
the patients and led to a decrease in the use of non-steroidal
anti-inﬂammatory drugs (NSAIDs) and to an early func-
tional recovery; the positive effect of the treatment was
maintained at a 3-year follow-up [22].
Arthroscopic reconstruction is the treatment of choice
following anterior cruciate ligament (ACL) rupture;
although minimally invasive, the procedure is associated
with joint reaction involving the synovia and it is expected
to lead to an increase of pro-inﬂammatory cytokines in the
synovial ﬂuid with catabolic effect on articular cartilage. In
this study, we evaluated whether the treatment with PEMFs
could be used to control joint inﬂammatory response in
patients undergoing ACL reconstruction. The end points of
the study were: (1) patients’ functional recovery evaluated
by International Knee Documentation Committee (IKDC)
form; (2) use of NSAIDs, necessary to control joint pain
and inﬂammation.
Materials and methods
Patients and study design
In 2004–2005, 84 patients undergoing ACL reconstruction
were evaluated for inclusion in the study at ﬁve clinical
centres. Of these, 69 gave their informed consent to par-
ticipate in the study. The prospective randomized and
double-blind study was approved by the local ethical
committees. Inclusion criteria were the following: age
between 18 and 45 years, ACL complete lesion following
acute trauma or consequence of ligament chronic degen-
eration. All lesions were documented by MRI and
conﬁrmed during the intervention. The following were the
exclusion criteria: osteonecrosis of the femoral condyle,
rheumatoid arthritis, autoimmune disease, systemic disease
and patients requiring meniscus repair.
The patients were assigned to the active or placebo
group according to the following randomization criteria:
age (18–30 or 31–45), sex, smoking status, origin of ACL
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123rupture (traumatic or degenerative). For randomization of
patients, a computer-generated schedule was prepared by a
biostatistician. In this process, a random number seed was
entered into the computer to generate a list that assigned
equal numbers of active and placebo stimulators. The
minimum number of patients per group required was cal-
culated by power analysis taking into account the results of
a previous study [22].
Of the 69 patients included, two never started the ther-
apy, two dropped out within 2 weeks of therapy, and ﬁve
did not return at follow-up visits; a total of 60 patients were
therefore available for subsequent analysis. The ACL
rupture occurred during sports activity in 49 patients (24
active and 25 placebo), daily activity in eight patients (four
active and four placebo) and trafﬁc accident in three
patients (three active). At the time of ACL reconstruction
29 patients underwent also meniscectomy: 15 in the active
group and 14 in the placebo.
Clinical evaluation
The patients were evaluated by IKDC Form before the
intervention and at 30, 60 and 180 days afterwards. The
different parts of the questionnaire, IKDC Current Health
Assessment Form (SF-36 Health Survey), IKDC Subjective
Knee Evaluation Form and IKDC Knee Examination Form
were analysed separately. As regards the scores of the
questionnaires, for each subject we considered the changes
at follow-up visits with respect to the values recorded at
baseline, before surgery.
Pain intensity was evaluated by visual analogue scale
(VAS) of 10-cm length: 0 cm no pain, 10 cm maximum
pain. The patients were allowed to use NSAIDs to control
knee pain when present and had to report doing so.
A 2-year follow-up telephone interview was conducted
and the patients were asked: (a) if they had undergone
further surgery at the knee, (b) if they had pain at the knee,
(c) if they had functional limitation in daily activity, (d) if
they returned to previous sport activity level.
Surgical technique
ACL arthroscopic repair was performed by quadruple
hamstrings semitendinosus and gracilis technique. Ten-
dons were harvested with the tendons stripper through a
2–3 cm vertical incision on the antero-medial tibial area.
Diameter of the quadruple hamstrings semitendinosus
and gracilis tendons was measured, while the tibial
tunnel and same size femoral tunnel (30 mm length)
were prepared. The graft was pulled up through the tibial
tunnel with the knee at 90 of ﬂexion and suspended on
the external femoral cortex (Endobutton, Smith and
Nephew, London, UK). Distally, the graft was ﬁxed with
an interference absorbable screw at the tibia at 10 of
ﬂexion.
Rehabilitation
All the patients underwent standard rehabilitation using
passive knee ﬂexion daily. Exercises started within the
third post-operative day with isometric quadriceps con-
tractions and then progressed to active closed-chain
exercises by 4–6 weeks postoperatively. During the ﬁrst
20 days patients were instructed to use two crutches and
then progressive weight bearing until the end of the second
month.
Biophysical stimulation
The patients were treated with active or placebo devices.
The active stimulators (I-ONE; IGEA, Carpi, Italy) gen-
erated a magnetic ﬁeld of peak intensity of 1.5 mT at a
frequency of 75 Hz; no heat or vibration was felt by the
patient during treatment (Fig. 1).
The patients were instructed to use the stimulator for 4 h
per day, not necessarily consecutively, for 60 days.
Treatment started within 7 days from the surgery. Each
device contained a clock to monitor the hours of use.
Fig. 1 Left I-ONE PEMFs
generator. Right wave form of
magnetic ﬁeld, 1.5 mT peak
value (top); electric ﬁeld
induced in a standard coil probe
made of 50 turns (0.5 cm [)o f
copper wire (0.2 mm [), peak
value 3 mV/cm (bottom)
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123Statistical analysis
The results were analysed with SPSS 13.0 (Statistical
Packages for Social Sciences Inc, Chicago, IL, USA).
Comparison among the continuous variables in the two
groupswasperformedwithStudent’sheteroschedasticttest;
comparison of continuous variables within each group dur-
ing follow-up was performed with Student’s paired t test.
Binomial and categorical variables were compared by
contingencytablesapplyingthechi-squaretestfor2 9 2tables
and the Cochran Mantel Haenszel test for larger size tables.
Generalized linear mixed effects model was applied to the
SF-36 Health Survey, IKDC Subjective Knee Evaluation and
VAS data to test if a different trend between the two groups
was present during follow-up by correcting for the following
covariates: sex, age, weight, height, hours of treatment,
smoking status, use of NSAIDs. In this analysis, a mathe-
matical model is built which takes into account the trend over
time of individual patients belonging to each group
(Group 9 Time interaction) and determines if a statistical
differenceexistsbetweenthegroupsduringthefollow-up[10].
The minimum signiﬁcance level for all the statistical
tests was set at P\0.05.
Results
At baseline, the two groups of study were homogeneous for
age, weight, height, VAS, SF-36 Health Survey and IKDC
Subjective Knee Evaluation score (Table 1).
Average daily treatment was the same in both groups:
3.92 ± 0.5 h/die versus 3.13 ± 0.3 h/die in the I-ONE
group and the placebo group, respectively (P = n.s.).
The average pain was modest and almost absent at
6 months’ follow-up: 0.7 ± 0.2 cm among placebo and
0.9 ± 0.2 cm among active. At 30 days, less patients in the
active group used NSAIDs: 8% in the I-ONE group versus
27% in the placebo group (P\0.05).
The SF-36 Health Survey score decreased signiﬁcantly
at 30 days, in both groups (P\0.0005). At 60 days the
mean SF-36 Health Survey score in the I-ONE patients
already exceeded the initial value (by 3.2 points), whereas
in the patients of the placebo group SF-36 Health Survey
score was slightly below the initial mean value (by -0.7
units). At 6 months a signiﬁcant (P\0.005) increase was
observed for SF-36 Health Survey average values in both
groups; the patients of the I-ONE group were above the
initial values by 10.1 units, while the placebo group
exceeds the baseline value by 7.2 units. The mean changes
of SF-36 Health Survey score in the I-ONE group are
systematically higher with respect to placebo during fol-
low-up, P\0.05 (Fig. 2).
The IKDC Subjective Knee Evaluation score increased
over 6 months and did not show signiﬁcant differences
between the two groups at any follow-up visit.
The IKDC Knee Examination Form outlined both groups
including subjects with joint swelling before surgery (one in
placebo and two in I-ONE group, P = n.s.) and at 30 days’
follow-up(ﬁveinplaceboandsixinI-ONEgroup,P = n.s.).
On day 60, joint swelling was observed in the placebo group
(two patients) only. Joint swelling was not observed any
moreat6 months’follow-up.Limitationinthepassiverange
ofmotionofthekneewasmorefrequentintheplacebogroup
than in the I-ONE group (P\0.05) (Fig. 3).
Table 1 Characteristics of the groups at baseline
Placebo
#29
I-ONE
#31
P
Mean SE Mean SE
Age 29.6 1.6 32.5 1.4 0.17
Weight 72 2 73 3 0.73
Height 175 1 174 2 0.59
VAS 2.4 0.3 3.2 0.5 0.27
SF-36 Health Survey 37 2 37 2 0.95
IKDC Subjective Knee Evaluation
Form
48 3 47 3 0.90
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Fig. 2 Mean changes of SF-36 Health Survey (±SE) versus baseline
in the two groups (P\0.05)
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Fig. 3 Patients with limitation in passive range of motion in the two
groups, P\0.05
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123Finally, the generalized linear mixed effects analysis
revealed a signiﬁcantly different trend (group 9 time
interaction, P\0.0001) between the two groups for SF-36
Health Survey score, IKDC Subjective Knee Evaluation
score and for VAS, showing a positive effect of I-ONE
treatment. The estimate coefﬁcients and signiﬁcance of
independent variables for three models are displayed in
Table 2.
At the 2-year follow-up interview 86% of the patients in
the I-ONE group and 75% in the placebo group reported
complete functional recovery, no knee pain and return to
sport activity.
ACL reconstruction and meniscectomy
When the cohort of patients, undergoing both ACL
reconstruction and meniscectomy, was analysed separately,
the SF-36 Health Survey score conﬁrmed the faster
recovery trend among I-ONE treated patients compared to
placebo, P\0.05 (Fig. 4). At 6 months, SF-36 Health
Survey average score increase was 11.4 in the I-ONE group
(P\0.005 vs. baseline) and 7.1 in placebo group (P = ns
vs. baseline). Further, the average values of SF-36 Health
Survey were signiﬁcantly higher in the I-ONE group
compared to the placebo (45.2 ± 1.5 vs. 37 ± 2.7,
P\0.05).
The percent of patients with limitation in the passive
range of motion was lower in the I-ONE group compared
to the placebo one (34% I-ONE vs. 50% placebo at day 30
and 4% I-ONE vs. 17% placebo at day 60, P\0.05).
Discussion
Arthroscopic surgery has gained a large success and led to
a signiﬁcant increase in its use: about 650,000 procedures
are performed in the USA each year [14]. However, the
access into the joint space is always associated to an
inﬂammatory reaction that may jeopardize the beneﬁts
expected from surgery. Joint inﬂammation has a catabolic
effect on extracellular matrix and inhibits chondrocyte
activity; thus, all means capable of locally controlling the
inﬂammation should be adopted to prevent the onset and
limit the progression of cartilage damage. Furthermore,
Table 2 Generalized linear mixed effects models in which the
dependent variables considered are: SF-36 Health Survey score,
IKDC Subjective Knee Evaluation score and VAS, respectively
Coefﬁcient Std. err. z test P\
SF-36 Health Survey
Group 0.361 2.690 0.13 0.893
Hours of treatment -0.014 0.008 -1.79 0.073
Sex -8.348 4.810 -1.74 0.083
Weight -0.423 0.171 -2.48 0.013
Height 0.220 0.254 0.87 0.386
Age -0.212 0.137 -1.55 0.120
Smoking status 0.768 2.075 0.37 0.711
Use of NSAIDs -4.667 2.726 -1.71 0.087
Time 0.125 0.034 4.58 0.000
Group 9 Time 0.051 0.014 3.67 0.0001
Constant 37.940 40.302 0.94 0.347
IKDC Subjective Knee Evaluation
Group -1.499 3.417 -0.44 0.661
Hours of treatment -0.007 0.011 -0.62 0.533
Sex -19.390 6.172 -3.14 0.002
Weight -0.578 0.216 -2.68 0.007
Height 0.150 0.322 0.47 0.642
Age -0.754 0.185 -4.08 0.000
Smoking status -2.214 2.783 -0.80 0.426
Use of NSAIDs -2.941 3.805 -0.77 0.440
Time 0.145 0.051 2.89 0.000
Group 9 Time 0.167 0.031 5.37 0.000
Constant 94.561 51.382 1.84 0.066
VAS
Group 0.799 0.455 1.76 0.079
Hours of treatment -0.000 0.001 -0.22 0.824
Sex 1.583 0.806 1.96 0.050
Weight 0.020 0.029 0.67 0.505
Height 0.027 0.043 0.64 0.524
Age 0.033 0.022 1.5 0.133
Smoking status 0.246 0.337 0.73 0.464
Use of NSAIDs -0.825 0.434 -1.90 0.058
Time -0.441 0.244 3.89 0.000
Group 9 Time -0.009 0.002 -4.00 0.000
Constant -5.593 6.721 -0.83 0.405
The Group 9 Time interaction term describes the different trend
between the groups
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Fig. 4 Patients undergoing ACL and meniscectomy: mean changes
of SF-36 Health Survey (±SE) versus baseline in the two groups
(P\0.05)
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123unlike bone tissue after damage, the cartilage will not
completely recover its competence: once lost, the articular
cartilage does not reform [13].
Many efforts are made to develop strategies able to
control joint inﬂammation and to favour the anabolic
activities of chondrocytes; these are challenging objectives,
and up to now the pharmacological approaches based on
the use of drugs, whether by systemic or by local route,
have not yet been able to demonstrate a genuine chon-
droprotective effect in humans [19].
Pre-clinical studies have shown PEMFs to have a
chondroprotective effect, mediated by the control of
inﬂammation and by the stimulation of chondrocyte
activity; thus, we hypothesized that after arthroscopic
surgery PEMFs treatment can be used for articular cartilage
protection and ultimately joint preservation.
This prospective, randomized and double-blind study
investigated whether and to what extent the employment
of I-ONE, by controlling joint reaction to arthroscopy,
could accelerate functional recovery in patients undergo-
ing ACL reconstruction. The I-ONE treatment was well
tolerated by the patients and no adverse side effects were
observed. The results show that, at 30 days after surgery,
in I-ONE group signiﬁcantly fewer patients used NSAIDs
to control pain, compared to patients in the placebo
group; afterwards, the use of NSAIDs was not necessary
in either group.
When IKDC Subjective Knee Evaluation average
scores were analysed, we found no statistically signiﬁcant
difference between the I-ONE and placebo group; this is
in agreement with the ﬁndings of other authors who
reported that this parameter does not correlate with the
other clinical information collected using the SF-36
Health Survey form [1]. However, when the results of the
two groups were analysed by generalized linear mixed
effects model, which takes into account the trend of each
patient in both groups and the effect of confounding
factors, we could evidence a positive signiﬁcant effect of
I-ONE treatment also in the Subjective Knee Evaluation
(Table 2).
The SF-36 Health Survey average scores at baseline
were the same in the I-ONE and placebo groups; however,
the high standard deviation testify the large distribution of
initial score values. To monitor patient’s recovery after
ACL reconstruction, we considered the SF-36 Health
Survey score changes with respect to baseline for each
individual subject. At 2 and 6 months SF-36 Health Survey
increase is undoubtedly higher in I-ONE group than in the
placebo group. This result indicates a faster recovery in the
treated patients. This positive effect of I-ONE treatment is
conﬁrmed by the generalized linear mixed effects analysis.
Further, when the cohort of patients who underwent both
ACL reconstruction and meniscectomy was analysed, we
observed that the average increase of SF-36 Health Survey
at 60 days in the I-ONE group was the same as that of
placebo group at 6 months (6.0 vs. 7.1, P = n.s.).
The IKDC Knee Examination Form showed how in the
placebo group the resolution of joint swelling and the
recovery of complete range of motion occur later compared
to the I-ONE group; no signiﬁcant difference in scoring
was observed among centres.
The study end-points were thus demonstrated: fewer
patients in the I-ONE group required the use of NSAIDs
and their functional recovery was faster.
At 2-year follow-up no statistically signiﬁcant differ-
ence was observed between two groups, although the
percent of patients with complete recovery was slightly
higher in the I-ONE group.
In this study we applied a statistical analysis speciﬁcally
developed for longitudinal studies that allows to calculate
the group 9 time interaction. This test, that considers
individual patient’s score at different time points and the
possible inﬂuence of confounding factors, supports the
positive effect of I-ONE treatment on the recovery of
patients undergoing ACL reconstruction.
Our data conﬁrm the results reported by Zorzi et al. [22]
in a group of patients treated with I-ONE following an
arthroscopic treatment for cartilage lesions. To the authors’
knowledge, there are no other reports of use of biophysical
stimulation after surgical procedures of the knee.
Biophysical stimulation allows treating individual joints,
permeating the whole cartilage surface and thickness, the
synovia and the subchondral bone. The effectiveness of
biophysical stimulation is not limited by considerations
such as diffusion ability and concentration gradient, which
are present and important in the dynamic of a pharmaco-
logical intervention; joint tissues are paramagnetic, they do
not attenuate the biophysical signal and thus are all hom-
ogenously exposed to the treatment efﬁcacy. Biophysical
stimulation is an effective therapeutic intervention to
control the detrimental consequences of the inﬂammation
over articular cartilage in the absence of negative side
effects.
I-ONE should always be considered after ACL recon-
struction, particularly in professional athletes, to shorten
the recovery time, to limit joint inﬂammatory reaction and
ultimately for joint preservation.
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